Hongru Kong

827 total citations
24 papers, 535 citations indexed

About

Hongru Kong is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Hongru Kong has authored 24 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Oncology. Recurrent topics in Hongru Kong's work include Pancreatitis Pathology and Treatment (4 papers), Cancer Cells and Metastasis (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Hongru Kong is often cited by papers focused on Pancreatitis Pathology and Treatment (4 papers), Cancer Cells and Metastasis (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Hongru Kong collaborates with scholars based in China, Sweden and United States. Hongru Kong's co-authors include Hongwei Sun, Mengtao Zhou, Bicheng Chen, Zongjing Chen, Liang Zhao, Shengjie Dai, Chunwu Zhang, Ying Li, Kun Tong and Haixin Qian and has published in prestigious journals such as PLoS ONE, Hepatology and Free Radical Biology and Medicine.

In The Last Decade

Hongru Kong

23 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongru Kong China 13 334 277 87 74 52 24 535
Susheng Miao China 14 327 1.0× 208 0.8× 59 0.7× 116 1.6× 60 1.2× 32 581
Yunxia Lv China 14 263 0.8× 159 0.6× 36 0.4× 80 1.1× 28 0.5× 31 469
Jinghua Gu United States 12 305 0.9× 156 0.6× 81 0.9× 87 1.2× 50 1.0× 33 541
Caiyong Lai China 13 259 0.8× 118 0.4× 40 0.5× 59 0.8× 25 0.5× 37 427
Lixuan Wei China 12 280 0.8× 128 0.5× 75 0.9× 122 1.6× 29 0.6× 34 515
Peng Xiao China 14 228 0.7× 135 0.5× 51 0.6× 83 1.1× 20 0.4× 25 401
Xionghui Mao China 16 401 1.2× 269 1.0× 62 0.7× 150 2.0× 133 2.6× 24 704
Qingjun He China 11 390 1.2× 334 1.2× 113 1.3× 51 0.7× 22 0.4× 18 610
Ni Chai China 7 259 0.8× 95 0.3× 51 0.6× 102 1.4× 73 1.4× 9 431

Countries citing papers authored by Hongru Kong

Since Specialization
Citations

This map shows the geographic impact of Hongru Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongru Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongru Kong more than expected).

Fields of papers citing papers by Hongru Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongru Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongru Kong. The network helps show where Hongru Kong may publish in the future.

Co-authorship network of co-authors of Hongru Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Hongru Kong. A scholar is included among the top collaborators of Hongru Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongru Kong. Hongru Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Luyao, Lei Fan, Hongru Kong, et al.. (2025). Repression of the ERRγ-CYP2E1 pathway by FGF4 mitigates alcohol-associated liver injury. Hepatology. 82(5). 1138–1154.
2.
Niu, Xiaoying, Ruicong Chen, Shengjie Dai, et al.. (2024). Enteral nutrition in the management of acute pancreatitis: Modulates gut microbiome and alleviates inflammation. Food Bioscience. 59. 103962–103962. 2 indexed citations
3.
Sun, Hong‐Wei, et al.. (2024). Transfection of 12/15-lipoxygenase effectively alleviates inflammatory responses during experimental acute pancreatitis. World Journal of Gastroenterology. 30(42). 4544–4556. 2 indexed citations
4.
Dai, Shengjie, et al.. (2024). Expression of the laminin genes family and its relationship to prognosis in pancreatic carcinoma. Arab Journal of Gastroenterology. 25(3). 306–314. 3 indexed citations
5.
Shi, Fengyu, Lingming Kong, Yuepeng Jin, et al.. (2023). KAN0438757, a novel PFKFB3 inhibitor, prevent the progression of severe acute pancreatitis via the Nrf2/HO-1 pathway in infiltrated macrophage. Free Radical Biology and Medicine. 210. 130–145. 7 indexed citations
6.
Kong, Hongru, et al.. (2023). The relationship between cancer and biomechanics. Frontiers in Oncology. 13. 1273154–1273154. 15 indexed citations
7.
Sun, Hongwei, Chongyun Xing, Songfu Jiang, et al.. (2022). Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-Cells plus sorafenib, a case report. Frontiers in Immunology. 13. 963031–963031. 15 indexed citations
8.
Sun, Hongwei, Hongru Kong, Bin Lou, et al.. (2022). Discoveries in Pancreatic Physiology and Disease Biology Using Single-Cell RNA Sequencing. Frontiers in Cell and Developmental Biology. 9. 732776–732776. 4 indexed citations
9.
Sun, Hongwei, Shengjie Dai, Hongru Kong, et al.. (2021). Accurate prediction of acute pancreatitis severity based on genome-wide cell free DNA methylation profiles. Clinical Epigenetics. 13(1). 223–223. 11 indexed citations
10.
Ding, Li, Shengjie Dai, Hao Pan, et al.. (2021). Development and Evaluation of Nomograms to Predict the Cancer‐Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma. BioMed Research International. 2021(1). 1658403–1658403. 13 indexed citations
11.
Kong, Hongru, et al.. (2021). Study of the Mechanism by Which Curcumin Cooperates with Sestrin2 to Inhibit the Growth of Pancreatic Cancer. Gastroenterology Research and Practice. 2021. 1–11. 5 indexed citations
12.
Shi, Keqing, Kai Qi, Hongru Kong, et al.. (2019). Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26. SSRN Electronic Journal. 8 indexed citations
13.
Yu, Huajun, Yunzhi Chen, Hongru Kong, et al.. (2018). The rat pancreatic body tail as a source of a novel extracellular matrix scaffold for endocrine pancreas bioengineering. Journal of Biological Engineering. 12(1). 6–6. 18 indexed citations
14.
Sun, Hongwei, Ying Li, Hongru Kong, Shengjie Dai, & Haixin Qian. (2018). Dysregulation of KCNQ1OT1 promotes cholangiocarcinoma progression via miR-140-5p/SOX4 axis. Archives of Biochemistry and Biophysics. 658. 7–15. 32 indexed citations
15.
Chen, Yunzhi, Fang Guo, Hongru Kong, et al.. (2017). Nuclear factor-κB signaling negatively regulates high glucose-induced vascular endothelial cell damage downstream of the extracellular signal-regulated kinase/c-Jun N-terminal kinase pathway. Experimental and Therapeutic Medicine. 14(4). 3851–3855. 3 indexed citations
16.
Zhao, Liang, Hongru Kong, Hongwei Sun, et al.. (2017). LncRNA‐PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR‐448. Journal of Cellular Physiology. 233(5). 4044–4055. 114 indexed citations
17.
Zhao, Liang, Hongwei Sun, Hongru Kong, et al.. (2017). The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382. Cellular Physiology and Biochemistry. 42(6). 2145–2158. 99 indexed citations
18.
Wang, Meng, et al.. (2015). Effects of capsicine on rat cytochrome P450 isoforms CYP1A2, CYP2C19, and CYP3A4. Drug Development and Industrial Pharmacy. 41(11). 1824–1828. 4 indexed citations
19.
Kong, Hongru, Guohua Dong, Kun Tong, et al.. (2014). Antitumor Efficacy of α-Solanine against Pancreatic Cancer In Vitro and In Vivo. PLoS ONE. 9(2). e87868–e87868. 50 indexed citations
20.
Kong, Hongru, Hongwei Sun, Roland Andersson, et al.. (2013). Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury. Experimental Biology and Medicine. 238(12). 1388–1395. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susheng Miao Breakdown of academic impact, for papers by Yunxia Lv Breakdown of academic impact, for papers by Jinghua Gu Breakdown of academic impact, for papers by Caiyong Lai Breakdown of academic impact, for papers by Lixuan Wei Breakdown of academic impact, for papers by Peng Xiao Breakdown of academic impact, for papers by Xionghui Mao Breakdown of academic impact, for papers by Qingjun He Breakdown of academic impact, for papers by Ni Chai
Rankless by CCL
2026